A team of researchers at Atara Biotherapeutics has conducted a small Phase I clinical trial of a therapeutic called ATA188 that targets Epstein-Barr infections (EBV) as a treatment for multiple sclerosis (MS). Representatives ...
Not all inflammation is created equal. While acute inflammation has evolved as the immune system's first response to protect the body, chronic inflammation can cause extensive and potentially irreversible damage, as commonly ...
Jan 20, 2022
0
250
Immune cells play a key role in mediating inflammatory responses. Dysregulation in signaling mechanisms that operate across immune cells can trigger chronic inflammatory diseases like rheumatoid arthritis that cause pain ...
Nov 24, 2021
0
12
Chronic inflammatory diseases, such as rheumatic diseases, psoriasis or chronic inflammatory bowel diseases are autoimmune diseases in which the immune system targets the body. This leads to misdirected inflammations in the ...
Mar 25, 2021
0
284
International Women's Day celebrates women's achievements and raises awareness of the continuing mission towards gender equality. So it's a good time to be reminded we still need to correct decades—centuries even—of gender ...
Mar 8, 2021
0
4
Researchers from the University of Vermont (UVM) have found that a bacterial species called Lactobacillus reuteri, commonly used in probiotics, can increase disease severity in a mouse model of multiple sclerosis (MS), an ...
Oct 19, 2020
0
259
Vitamin D is recognized as an important co-factor in several physiological processes linked with bone and calcium metabolism, and also in diverse non-skeletal outcomes, including autoimmune diseases, cardiovascular diseases, ...
Jul 27, 2020
0
39
As the COVID-19 pandemic continues to spread, researchers are turning their attention to the virus' biology, mechanism of action, and possible treatments. One of the targets is a group of immune cells called neutrophils, ...
Jun 2, 2020
0
93
Argenx, a Belgian drug maker, recently announced a successful phase 3 ADAPT trial of its experimental drug, efgartigimod. The company plans to seek U.S. approval of the drug by the end of year as a potential new treatment ...
May 29, 2020
0
12
Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs' potentially serious adverse ...
Apr 8, 2020
0
112
